The iShares Nasdaq Biotechnology ETF (IBB) is poised to open higher on Friday, boosted by Federal Reserve Chair Janet Yellen’s positive comments on the economy. Among …
The biotech sector is taking center stage this week as several key players are scheduled to announced earnings. Investors and analysts are looking …
Juno Therapeutics Inc (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, and Fred Hutchinson Cancer …
Maxim’s healthcare analyst Jason McCarthy weighed in today on cancer-drug maker Juno Therapeutics Inc (NASDAQ:JUNO) and cancer-vaccine maker Inovio Pharmaceuticals Inc (NASDAQ:INO). The analyst reflects on Juno’s opportunity in …
FBR analysts are out with a commentary on updates announced by biotech stocks Juno Therapeutics Inc (NASDAQ:JUNO) and Peregrine Pharmaceuticals (NASDAQ:PPHM). Juno Therapeutics Inc FBR analyst Edward …
While JP Morgan Healthcare Conference, which has become an agenda-setting meeting for pharma and biotech, is taking place in San Francisco, J.P.
Juno Therapeutics Inc (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, announced today that it …
Juno Therapeutics Inc (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced, in partnership …
Juno Therapeutics Inc (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced the Company, …
Juno Therapeutics Inc (NASDAQ:JUNO) shares are trading down 1.29% to 51.
